BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25028361)

  • 1. Serine Proteinase Inhibitor SERPINA3K Suppresses Corneal Neovascularization via Inhibiting Wnt Signaling and VEGF.
    Zhou T; Chen L; Huang CH; Lin Z; Zong R; Zhu C; Pan F; Ma JX; Liu ZG; Zhou Y
    Invest Ophthalmol Vis Sci; 2014 Jul; ():. PubMed ID: 25028361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SERPINA3K Ameliorates the Corneal Oxidative Injury Induced by 4-Hydroxynonenal.
    Zheng X; Cui H; Yin Y; Zhang Y; Zong R; Bao X; Ma JX; Liu Z; Zhou Y
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2874-2883. PubMed ID: 28586911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-Regulation of MicroRNA-184 Is Associated With Corneal Neovascularization.
    Zong R; Zhou T; Lin Z; Bao X; Xiu Y; Chen Y; Chen L; Ma JX; Liu Z; Zhou Y
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1398-407. PubMed ID: 27018842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.
    Zhang B; Zhou KK; Ma JX
    Diabetes; 2010 Jul; 59(7):1809-16. PubMed ID: 20299474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.
    Liu X; Lin Z; Zhou T; Zong R; He H; Liu Z; Ma JX; Liu Z; Zhou Y
    PLoS One; 2011 Jan; 6(1):e16712. PubMed ID: 21304961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERPINA3K plays antioxidant roles in cultured pterygial epithelial cells through regulating ROS system.
    Zhu C; Pan F; Ge L; Zhou J; Chen L; Zhou T; Zong R; Xiao X; Dong N; Yang M; Ma JX; Liu Z; Zhou Y
    PLoS One; 2014; 9(10):e108859. PubMed ID: 25296038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.
    Zhang B; Abreu JG; Zhou K; Chen Y; Hu Y; Zhou T; He X; Ma JX
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6900-5. PubMed ID: 20351274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
    Zhang B; Hu Y; Ma JX
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of corneal neovascularization by curcumin
    Zhang YK; Li JM; Qin L
    Int J Ophthalmol; 2017; 10(12):1791-1797. PubMed ID: 29259894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gap26 inhibited angiogenesis through the β-catenin-VE-cadherin-VEGFR2-Erk signaling pathway.
    Xu C; Zhong W; Zhang H; Jiang J; Zhou H
    Life Sci; 2023 Sep; 328():121836. PubMed ID: 37295713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERPINA3K protects against oxidative stress via modulating ROS generation/degradation and KEAP1-NRF2 pathway in the corneal epithelium.
    Zhou T; Zong R; Zhang Z; Zhu C; Pan F; Xiao X; Liu Z; He H; Ma JX; Liu Z; Zhou Y
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5033-43. PubMed ID: 22736614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pirfenidone in alkali burn rat cornea.
    Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
    Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
    Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
    Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitor A3K suppressed the formation of ocular surface squamous metaplasia in a mouse model of experimental dry eye.
    Lin Z; Zhou Y; Wang Y; Zhou T; Li J; Luo P; He H; Wu H; Liu Z
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5813-20. PubMed ID: 25103264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
    Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
    Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
    Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Endoplasmic Reticulum-Stressed Head and Neck Squamous Cell Carcinoma Cells Induced Exosomal miR-424-5p Inhibits Angiogenesis and Migration of Humanumbilical Vein Endothelial Cells Through LAMC1-Mediated Wnt/β-Catenin Signaling Pathway.
    Wang Z; Jiao P; Zhong Y; Ji H; Zhang Y; Song H; Du H; Ding X; Wu H
    Cell Transplant; 2022; 31():9636897221083549. PubMed ID: 35315295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonated Formononetin Induces Angiogenesis through Vascular Endothelial Growth Factor/cAMP Response Element-Binding Protein/Early Growth Response 3/Vascular Cell Adhesion Molecule 1 and Wnt/β-Catenin Signaling Pathway.
    Dong Z; Shi Y; Zhao H; Li N; Ye L; Zhang S; Zhu H
    Pharmacology; 2018; 101(1-2):76-85. PubMed ID: 29131133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.